These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8913670)

  • 1. Potential advantages of novel antithrombotic agents administered conjunctively during coronary fibrinolysis.
    Abendschein DR
    Coron Artery Dis; 1996 Jul; 7(7):522-7. PubMed ID: 8913670
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood coagulation and fibrinolysis.
    Heimburger N; Trobisch H
    Angew Chem Int Ed Engl; 1971 Feb; 10(2):85-97. PubMed ID: 4995468
    [No Abstract]   [Full Text] [Related]  

  • 3. Is fibrinolysis critical for acute coronary syndromes?
    Kluft C; Andreotti F
    Ital Heart J; 2001 Sep; 2(9):639-40. PubMed ID: 11666088
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapy with thrombolytic agents in coronary artery disease.
    Hanna GP; Smalling RW
    Curr Opin Cardiol; 1998 Jul; 13(4):267-73. PubMed ID: 10091022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical experience with hemocoagulative and fibrinolytic equilibrium in coronary disease].
    Facchini G; Posteli T; Cremonini G; Bortolotti G; Addarii F
    Atti Soc Ital Cardiol; 1968; 2():122-3. PubMed ID: 5717486
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombosis, antithrombotic agents, and the antithrombotic approach in cardiac disease.
    Schussheim AE; Fuster V
    Prog Cardiovasc Dis; 1997; 40(3):205-38. PubMed ID: 9406677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjunctive antithrombotic and thrombolytic therapy for coronary-artery occlusion.
    Gold HK
    N Engl J Med; 1990 Nov; 323(21):1483-5. PubMed ID: 2233922
    [No Abstract]   [Full Text] [Related]  

  • 8. 3rd Congress on Thrombosis and Hemostasis. Berne, February 15-18, 1984.
    Blut; 1984 Aug; 49(2):117-84. PubMed ID: 6466882
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinolysis and its pharmacological enhancement in occlusive vascular disease.
    Fearnley GR
    Adv Cardiol; 1970; 4():211-24. PubMed ID: 4924083
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease.
    Fujinishi A; Takahara K; Ohba C; Nakashima Y; Kuroiwa A
    Angiology; 1997 Jun; 48(6):515-21. PubMed ID: 9194537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antithrombotic therapy of ischemic heart disease].
    Liusov VA; Belousov IuB
    Kardiologiia; 1974 Jul; 14(7):113-21. PubMed ID: 4431131
    [No Abstract]   [Full Text] [Related]  

  • 12. Relation of depression to various markers of coagulation and fibrinolysis in patients with and without coronary artery disease.
    Schroeder V; Borner U; Gutknecht S; Schmid JP; Saner H; Kohler HP
    Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):782-7. PubMed ID: 18043299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs.
    Abendschein DR; Baum PK; Verhallen P; Eisenberg PR; Sullivan ME; Light DR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):567-72. PubMed ID: 11160645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anginin (pyridinol carbamate) therapy of coronary atherosclerosis and obliterating atherosclerosis of the arteries of the lower extremities].
    Liusov VA; Belousov IuB; Martynov AI; Koroleva SA; Zimin VS
    Kardiologiia; 1972 Nov; 12(11):39-45. PubMed ID: 4655879
    [No Abstract]   [Full Text] [Related]  

  • 15. [Advances in the field of blood coagulation].
    Hauck G; Schröer H
    Hippokrates; 1969 Jan; 40(1):2-8. PubMed ID: 4895513
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemostatic factors and inhibitors and coronary artery bypass grafting: preoperative alterations and relations to graft occlusion.
    Moor E; Hamsten A; Blombäck M; Herzfeld I; Wiman B; Rydén L
    Thromb Haemost; 1994 Sep; 72(3):335-42. PubMed ID: 7531874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of thrombolytic therapy.
    Sherry S
    J Am Coll Cardiol; 1987 Oct; 10(4):933-4. PubMed ID: 3655157
    [No Abstract]   [Full Text] [Related]  

  • 18. Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial.
    Brouwer MA; Kievit PC; Dieker HJ; Veen G; Karreman AJ; Verheugt FW
    Am Heart J; 2008 Jun; 155(6):1039-46. PubMed ID: 18513517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disseminated intravascular coagulation].
    Amir J
    Harefuah; 1972 Jul; 83(1):29-32. PubMed ID: 4264530
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombin and antithrombotics.
    Fenton JW; Ofosu FA; Brezniak DV; Hassouna HI
    Semin Thromb Hemost; 1998; 24(2):87-91. PubMed ID: 9579630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.